Ex vivo amplification of human hematopoietic stem and progenitor cells in an alginate three-dimensional culture system

International Journal of Laboratory Hematology

Volumn 33, Issue 5, 2011, Pages 516-525

  Yuan, Y ^a,b   Tse, K T ^c   Sin, F W Y ^a   Xue, B ^a   Fan, H H ^d   Xie, Y ^a,b  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

^c QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^d Shanghai Blood Center   (China)

Author keywords

Cord blood; Hematopoietic progenitor cells; Hematopoietic stem cells; Three dimensional culture system

Indexed keywords

ALGINIC ACID; GELATIN;

ARTICLE; CELL CULTURE; CELL ENCAPSULATION; CELL EXPANSION; COLONY FORMING CELL; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 80051917547     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01324.x     Document Type: Article

References (23)

1. Bienaime C., Barbotin J.N. & Nava-Saucedo J.E. (2003) How to build an adapted and bioactive cell microenvironment? A chemical interaction study of the structure of Ca-alginate matrices and their repercussion on confined cells. Journal of Biomedical Materials Research. Part A 67, 376-388.
2. Brown J.A. & Boussiotis V.A. (2008) Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clinical Immunology 127, 286-297.
3. Chao N.J., Emerson S.G. & Weinberg K.I. (2004) Stem cell transplantation (cord blood transplants). Hematology/the Education Program of the American Society of Hematology 2004, 354-371.
4. Cohen Y. & Nagler A. (2004) Cord blood biology and transplantation. Israel Medical Association Journal 6, 39-46.
5. Dazzi F., van Laar J.M., Cope A. & Tyndall A. (2007) Cell therapy for autoimmune diseases. Arthritis Research & Therapy 9, 206.
6. Ehring B., Biber K., Upton T.M., Plosky D., Pykett M. & Rosenzweig M. (2003) Expansion of HPCs from cord blood in a novel 3D matrix. Cytotherapy 5, 490-499.
7. Farber J.L. (1990) The role of calcium ions in toxic cell injury. Environmental Health Perspectives 84, 107-111.
8. + selected cells. Bone Marrow Transplantation 23, 1109-1115.
9. Gluckman E., Rocha V., Arcese W., Michel G., Sanz G., Chan K.W., Takahashi T.A. et al. (1997) Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. The New England Journal of Medicine 337, 373-381.
10. Gluckman E., Rocha V., Arcese W., Michel G., Sanz G., Chan K.W., Takahashi T.A., Ortega J., Filipovich A., Locatelli F., Asano S., Fagioli F., Vowels M., Sirvent A., Laporte J.P., Tiedemann K., Amadori S., Abecassis M., Bordigoni P., Diez B., Shaw P.J., Vora A., Caniglia M., Garnier F., Ionescu I., Garcia J., Koegler G., Rebulla P., Chevret S. & Eurocord Group. (2004) Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Experimental Hematology 32, 397-407.
11. Heise M., Koepsel R., Russell A.J. & McGee E.A. (2005) Calcium alginate microencapsulation of ovarian follicles impacts FSH delivery and follicle morphology. Reproductive Biology and Endocrinology 3, 47.
12. Hofmeister C.C., Zhang J., Knight K.L., Le P. & Stiff P.J. (2007) Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplantation 39, 11-23.
13. + cells in a collagen bead-containing 3-dimensional culture system. International Journal of Hematology 78, 126-132.
14. Koch S., Schwinger C., Kressler J., Heinzen C.H. & Rainov N.G. (2003) Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. Journal of Microencapsulation 20, 303-316.
15. Magyar J.P., Nemir M., Ehler E., Suter N., Perriard J.C. & Eppenberger H.M. (2001) Mass production of embryoid bodies in microbeads. Annals of the New York Academy of Sciences 944, 135-143.
16. Marmont A.M. (1998) Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 83, 733-743.
17. Migliaccio A.R., Adamson J.W., Stevens C.E., Dobrila N.L., Carrier C.M. & &Rubinstein P. (2000) Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 96, 2717-2722.
18. Oca-Cossio J., Simpson N.E., Han Z., Stacpoole P.W. & Constantinidis I. (2005) Effects of alginate encapsulation on mitochondrial activity. Journal of Materials Science. Materials in Medicine 16, 521-524.
19. Piacibello W., Sanavio F., Garetto L., Severino A., Bergandi D., Ferrario J., Fagioli F., Berger M. & Aglietta M. (1997) Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89, 2644-2653.
20. Piacibello W., Sanavio F., Garetto L., Severino A., Dané A., Gammaitoni L. & Aglietta M. (1998) Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 12, 718-727.
21. Rice A., Flemming C., Case J., Stevenson J., Gaudry L. & Vowels M. (1999) Comparative study of the in vitro behavior of cord blood subpopulations after short-term cytokine exposure. Bone Marrow Transplantation 23, 211-220.
22. Tyndall A. & Saccardi R. (2005) Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clinical and Experimental Immunology 141, 1-9.
23. Wee S. & Gombotz W.R. (1998) Protein release from alginate matrices. Advanced Drug Delivery Reviews 31, 267-285.